Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Publisher Correction to: Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities.
Michelozzi, P; De'Donato, F; SCORTICHINI, M; Pezzotti, P; Stafoggia, M; De Sario, M; Costa, G; Noccioli, F; Riccardo, F; Bella, A; Demaria, M; Rossi, P; Brusaferro, S; Rezza, G; Davoli, M;
2020
BMC PUBLIC HEALTH, (2020).20 1 10.1186/s12889-020-09398-7.
Optimising social mixing strategies to mitigate the impact of COVID-19 in six European countries: a mathematical modelling study.
Ragonnet, R; Briffoteaux, G; Williams, B; Savulescu, J; Segal, M; Abayawardana, M; EGGO, R; Tuyttens, D; Melab, N; Marais, B; McBryde, E; Trauer, J;
2020
medRxiv (2020). 10.1101/2020.08.25.20182162.
Transmission risk of respiratory viruses in natural and mechanical ventilation environments: implications for SARS-CoV-2 transmission in Africa.
Sopeyin, A; Hornsey, E; Okwor, T; Alimi, Y; Raji, T; Mohammed, A; Moges, H; Onwuekwe, EV C; Minja, FJ; GON, G; Ogbuagu, O; Ogunsola, F; Paintsil, E;
2020
BMJ global health, (2020).5 8 10.1136/bmjgh-2020-003522.
Antibody response to SARS-CoV-2 infection in humans: a systematic review.
Post, N; Eddy, D; Huntley, C; Van Schalkwyk, MC I; Shrotri, M; Leeman, D; Rigby, S; Williams, SV; Bermingham, WH; Kellam, P; Maher, J; Shields, AM; Amirthalingam, G; Peacock, SJ; ISMAIL, SA;
2020
(2020). 10.1101/2020.08.25.20178806.
Cellular immune response to SARS-CoV-2 infection in humans: a systematic review.
Shrotri, M; VAN SCHALKWYK, MC I; Post, N; Eddy, D; Huntley, C; Leeman, D; Rigby, S; Williams, SV; Bermingham, WH; Kellam, P; Maher, J; Shields, AM; Amirthalingam, G; Peacock, SJ; ISMAIL, SA;
2020
medRxiv preprint - BMJ Yale (2020). 10.1101/2020.08.24.20180679.
Disability-inclusive responses to COVID-19: Lessons learnt from research on social protection in low- and middle-income countries.
BANKS, LM; DAVEY, C; SHAKESPEARE, T; KUPER, H;
2020
WORLD DEVELOPMENT, (2020).137, 10.1016/j.worlddev.2020.105178.
COVID-19 vaccine trials should seek worthwhile efficacy.
Krause, P; Fleming, TR; Longini, I; Henao-Restrepo, AM; Peto, R; World Health Organization Solidarity Vaccines Tria,;
2020
The Lancet, (2020).396 10253 10.1016/S0140-6736(20)31821-3.
Opening the third space between laboratory research and public policy during the Covid-19 pandemic.
PAGANOPOULOS, M;
2020
ASA monograph (2020).
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.
WALKER, JL; GRINT, DJ; STRONGMAN, H; EGGO, RM; Peppa, M; MINASSIAN, C; MANSFIELD, KE; RENTSCH, CT; DOUGLAS, IJ; MATHUR, R; WONG, AY S; Quint, JK; Andrews, N; Bernal, JL; SCOTT, JA; Ramsay, M; SMEETH, L; MCDONALD, H;
2020
MedRxiv (2020). 10.1101/2020.08.24.20179192.
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
Abu Raddad, L; CHEMAITELLY, H; Malek, J; Malek, J; Ahmed, A; Mohamoud, Y; Younuskunju, S; Ayoub, H; Kanaani, ZA; Khal, AA; Kuwari, EA; Butt, A; Coyle, P; Jeremijenko, A; Kaleeckal, AH; Latif, AN; Shaik, RM; Abdul Rahim, H; Yassine, H; Al Kuwari, M; Romaihi, HE A; Al Thani, SM; Bertollini, R;
2020
medRxiv (2020). 10.1101/2020.08.24.20179457.